PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 7184469

Experimental acantholysis by complement-fixing intercellular antibodies.

T Hashimoto·M Sugiura·S Kurihara·T Nishikawa·H Hatano
View original source ↗Export metadata ↓

Abstract

Complement-fixing intercellular antibodies were detected in 10 of 17 sera from untreated pemphigus patients. The role of complement in the organ culture system was investigated using these sera. Ten sera possessing complement-fixing intercellular antibodies showed IgG binding to the intercellular substance in the organ-cultured skin and acantholysis-like changes were observed in eight cases. C3 deposition was not seen in any case. However, after treatment of the sections of cultured skin with fresh normal human serum, complement fixation of the intercellular substance by bound IgG was revealed in all the ten cases. No significant differences in the grade of acantholysis-like changes between the complement-depleted system and the complement-supplied system were observed. Complement does not appear to be necessary in the acantholytic process in the in vitro organ culture system, even though we considered the presence of complement-fixing intercellular antibodies.

Explore related subjects

AcantholysisAntibodiesComplement System ProteinsHumansOrgan Culture TechniquesPemphigusSkin DiseasesJournal ArticleResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

T Hashimoto, M Sugiura, S Kurihara, T Nishikawa, H Hatano. 1982. Experimental acantholysis by complement-fixing intercellular antibodies.. https://doi.org/10.1007/bf00509037

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1998

Incidental focal acantholytic dyskeratosis.

BACKGROUND: Focal acantholytic dyskeratosis is a distinctive histologic pattern characterized by (1) suprabasilar clefts around preserved papillae, (2) acantholytic and dyskeratotic cells at all levels of the epidermis, and (3) hyperkeratosis and parakeratosis. These histologic changes have been observed as an incidental finding in a variety of skin lesions. OBJECTIVE: Our purpose was to identify the lesions associated with incidental focal acantholytic dyskeratosis. METHODS: Eight specimens containing incidental focal acantholytic dyskeratosis were retrospectively evaluated, and the published literature describing lesions with incidental focal acantholytic dyskeratosis was reviewed. RESULTS: The ages of the eight patients ranged from 29 to 53 years. Incidental focal acantholytic dyskeratosis was seen in nevi with architectural disorder (four lesions), scars (two lesions), a ruptured follicle (one lesion), and a seborrheic keratosis (one lesion). Incidental focal acantholytic dyskeratosis was either present in the "clinically normal-appearing" skin adjacent to the lesion (five lesions) or within the lesion (three lesions). Twenty-one additional cases of incidental focal acantholytic dyskeratosis have previously been reported. CONCLUSION: Incidental focal acantholytic dyskeratosis has been described in benign and malignant epithelial lesions, fibrohistiocytic lesions, inflammatory lesions, melanocytic lesions, and miscellaneous lesions. This pathologic change was observed either within the actual lesion or in the immediately adjacent epithelium. The cause of this clinically benign, microscopically intriguing condition remains to be determined.

Acantholysis↗
PubMed1998

Different patterns of in vitro acantholysis in normal human skin samples explanted from different sites of the body.

BACKGROUND: The factors that contribute to a preferential anatomic localization of pemphigus lesions are not well known. In particular, the question arises as to whether certain skin areas may be more acantholysis-prone than others. OBJECTIVE: To verify whether, in pemphigus patients, a different susceptibility to acantholysis exists among different cutaneous regions, the technique of tissue cultures was used. METHODS: Normal human skin explants from two distinct anatomic regions (back and buttocks) of two former pemphigus patients were cultured in vitro in the presence of enalapril (6 mM) or cystamine (10 mM), two substances with a proven biochemical acantholytic effect. After 4 days of culture, the tissues were processed for standard histology. RESULTS: Diffuse acantholysis, with large intraepidermal splits, was observed in the explants taken from the backs of both subjects and cultured with either enalapril or cystamine. Mild to moderate acantholytic changes were detected in the explants taken from the buttocks of both subjects and cultured with either enalapril or cystamine. No structural changes were seen in the control cultures. CONCLUSIONS: Pemphigus patients present different thresholds of acantholysis in different areas of their bodies. This might explain, at least in part, certain preferential anatomic localizations of pemphigus lesions.

Acantholysis↗
PubMed1998

Grover's-like disease in the setting of bone marrow transplantation and autologous peripheral blood stem cell infusion.

Four cases of a Grover's-like disease in patients with leukemia/lymphoma, who underwent high-dose chemotherapy and either allogeneic/autologous bone marrow transplantation or autologous stem cell infusion, are described. Three of four patients had fever prior to the onset of their rash. In addition to suprabasilar clefts, acantholysis, and dyskeratosis, typical of Grover's disease, there was a chemotherapeutic effect in the form of keratinocytes with atypical nuclei. So-called "starburst cells," which have been purported to be specific for high-dose etoposide (VP-16) therapy, were seen in two cases, but only one of these patients received etoposide. In one patient with clinical vesicles, direct immunofluorescence ruled out paraneoplastic pemphigus. In conjunction with 18 similar cases in the literature, the following conclusions were reached: (a) the pathogenesis probably involves the combined effects of fever (with sweating), occlusion, and chemo/radiation therapy; (b) no single chemotherapeutic agent can be consistently implicated; and (c) in addition to graft-versus-host disease, the eruption of lymphocyte recovery, and other cutaneous eruptions in the setting of bone marrow transplantation, the differential diagnosis includes paraneoplastic pemphigus, which direct immunofluorescence excludes.

Acantholysis↗